![]()
|
Report Date : |
18.12.2008 |
IDENTIFICATION
DETAILS
|
Name : |
R. P. TRADERS |
|
|
|
|
Registered Office : |
218, 2nd Floor, Vardhman City Centre, Shakti Nagar, New
Delhi-110052 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2008 |
|
|
|
|
Year of Establishment : |
1999 |
|
|
|
|
IEC No.: |
0599003596 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
DELS24709G |
|
|
|
|
PAN No.: [Permanent
Account No.] |
ALMPS8614F |
|
|
|
|
Legal Form : |
Sole Proprietory Concern |
|
|
|
|
Line of Business : |
Trader and Exporter of All types of Pharmaceutical Formulations |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 25000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well – established and reputed concern meetings its
normal commitments timeously. Trade relations are fair. Business is active. Nothing adverse reported. The concern can be considered good for normal business dealings. |
INFORMATION PARTED
BY
|
Name : |
Mr. Satbir Singh Mendiratta |
|
Designation : |
Proprietor |
|
Contact No.: |
91-9811212687 |
|
Date : |
02.07.2008 |
INFORMATION PARTED
BY
|
Name : |
Mr. Satbir Singh |
|
Designation : |
Proprietor |
|
Contact No.: |
Mobile no.91-9811212687 |
|
Date : |
16.12.2008 |
LOCATIONS
|
Registered Office : |
218, 2nd Floor, Vardhman City Centre, Shakti Nagar, New
Delhi-110052, India |
|
Tel. No.: |
91-11 – 23659411 / 23659413 / 23643221 |
|
Mobile No.: |
91-919811212686 / 9811212687 / 9899201411 |
|
Fax No.: |
91-11-23644966 |
|
E-Mail : |
rptraders@gmail.com |
|
Website : |
|
|
Area : |
279 Sq.fts |
|
Location : |
Owned |
SOLE PROPRIETOR
|
Name : |
Mr. Satbir Singh Mendiratta |
|
Designation : |
Proprietor |
|
Address : |
E – 10, Ashok Vihar, Phase – I, Delhi – 110 052, India |
|
Date of Birth/Age : |
35 Years |
|
Qualification : |
10th |
|
Experience : |
17 Years |
BUSINESS DETAILS
|
Line of Business : |
Trader and Exporter of All types of Pharmaceutical Formulations |
|
|
|
|
Products : |
Injections, Capsules, Tablets, Suspension, Syrups, Ointmants, Anti
Cancer Formulations and Pharmaceutical Formulation |
|
|
|
|
Exports : |
|
|
Products : |
Injections, Capsules, Tablets, Suspension, Syrups, Ointmants, Anti Cancer
Formulations and Pharmaceutical Formulation |
|
Countries : |
Singapore, Myanmar |
|
|
|
|
Terms : |
|
|
Selling : |
L/C, Cash and Advance Payment |
|
|
|
|
Purchasing : |
Cash and Credit 30-60 days |
GENERAL
INFORMATION
|
Suppliers : |
Wellco Pharma, Bhadurgarh, Haryana |
|
|
|
|
Customers : |
Wholesalers East Village, Singapore |
|
|
|
|
No. of Employees : |
8 |
|
|
|
|
Bankers : |
|
|
|
|
|
Auditors : |
|
|
Name : |
Yogesh Kapoor and Associates Chartered Accountants |
|
Address : |
New Delhi – 110 055, India |
|
|
|
|
Banking Relations : |
Satisfactory |
|
|
|
|
Associates/Subsidiaries : |
S.D. Wool Agencies ( Pharma Division ) Started in : 2007 S.D. International Address: Chandani Chawk, New Delhi Line of business: Trader and Exporter of All types of Pharmaceutical
Formulations |
CAPITAL STRUCTURE
|
Capital Investment : |
|
|
Owned : |
Rs. 5.083 millions |
|
Borrowed : |
--- |
|
Total : |
Rs. 5.083 millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
|
31.03.2008 |
31.03.2007 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Proprietor’s Capital |
|
5.083 |
4.505 |
|
|
2] Share Application Money |
|
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
|
0.000 |
0.000 |
|
|
4] (Accumulated Losses) |
|
0.000 |
0.000 |
|
|
NETWORTH |
|
5.083 |
4.505 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
1.264 |
0.316 |
|
|
2] Unsecured Loans |
|
0.600 |
0.600 |
|
|
TOTAL BORROWING |
|
1.864 |
0.916 |
|
|
DEFERRED TAX LIABILITIES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
6.947 |
5.421 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
2.536 |
1.393 |
|
|
Capital work-in-progress |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
0.000 |
0.220 |
|
|
Sundry Debtors |
|
9.445 |
6.886 |
|
|
Cash & Bank Balances |
|
2.153 |
3.663 |
|
|
Other Current Assets |
|
0.000 |
0.000 |
|
|
Loans & Advances |
|
0.537 |
0.394 |
|
Total
Current Assets |
|
12.135 |
11.163 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
|
7.724 |
7.135 |
|
|
Provisions |
|
0.000 |
0.000 |
|
Total
Current Liabilities |
|
7.724 |
7.135 |
|
|
Net Current Assets |
|
4.411 |
4.028 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
6.947 |
5.421 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
|
31.03.2008 |
31.03.2007 |
|
|
Sales Turnover |
|
43.681 |
47.881 |
|
|
Other Income |
|
0.000 |
0.125 |
|
|
Total Income |
|
43.681 |
48.006 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
|
1.015 |
1.104 |
|
|
Provision for Taxation |
|
0.000 |
0.000 |
|
|
Profit/(Loss) After Tax |
|
1.015 |
1.104 |
|
|
|
|
|
|
|
|
Earnings in Foreign Currency : |
|
|
|
|
|
|
Export Earnings |
|
42.163 |
45.814 |
|
|
Other Earnings |
|
1.518 |
2.004 |
|
Total Earnings |
|
43.681 |
47.818 |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Cost of Goods Sold |
|
33.858 |
35.967 |
|
|
Administrative Expenses |
|
4.661 |
6.538 |
|
|
Interest |
|
0.194 |
0.143 |
|
|
Depreciation & Amortization |
|
0.588 |
0.343 |
|
|
Other Expenditure |
|
3.365 |
3.911 |
|
Total Expenditure |
|
42.666 |
46.902 |
|
Expected Sales (2008-09): Rs.60.000 millions
KEY RATIOS
|
PARTICULARS |
|
|
31.03.2008 |
31.03.2007 |
|
PAT / Total Income |
(%) |
|
2.32 |
2.30 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
|
2.32 |
2.31 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
|
6.92 |
8.79 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
|
0.20 |
0.25 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
|
1.89 |
1.79 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
|
1.57 |
1.56 |
LOCAL AGENCY
FURTHER INFORMATION
|
Additional
Requirement of Indiamart for Trust-Seal |
|
|
|
|
|
VAT / TIN : 07880213097 |
|
|
IEC Code : 0599003596 |
|
|
|
|
|
PAN / TAN : PAN
No.ALMPS8614F TAN No.DELS24709G |
|
|
|
|
|
Bank Name : HDFC Bank Limited |
|
|
Bank Address : 10166-67,
Gurudwara
Road, Karol Bagh, New Delhi – 110 005, India |
|
|
Bank A/c. No.: C/A
No.111002000012131 |
|
|
Account Since : 1999 |
|
|
|
|
|
In case of any affiliations / memberships / certifications
: |
|
|
Name : FIEO /
PHARMEXCIL |
|
|
Type : RCMC |
|
|
Expiry Date : 31.03.2009
/ 31.03.2010 |
|
FIXED ASSETS:
WEBSITE DETAILS:
PROFILE:
With almost a decade
of partnering life and engendering hope, they are an eminent generic
pharmaceutical company. They believe that access to quality health care is a
right, not a privilege. The endeavor is to ensure the availability of world
class, quality medicines at affordable prices, across the globe. They are
committed to work towards a healthier and happier world. Subject, established in 1999 is a
distinguished exporter and trader
of Capsules, Ear Drops, External
Preparations, Ophthalmic Preparations, Oral Liquid, Oral Solution,
Parenteral Liquid Preparations, Nasal Drops, etc. They are affiliated to
the prestigious Pharmaceutical Export Promotion Council (Pharmexcil) and the
Federation of Indian Export Organisations (FIEO).
The Product
Catalog
Headquartered in
Delhi, Subject is an integrated international pharmaceutical company, exporting
and trading in a wide range of quality, affordable generic medicines, trusted
by health care professionals and patients across geographies. The product range
comprises of the following:-
Biological Oral Liquid
Biological Ear Drops
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the the concern is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair and
reasonable and comparable to compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a the concern’s management, its Board of Directors, Shareholders and
other financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.47.33 |
|
UK Pound |
1 |
Rs.73.92 |
|
Euro |
1 |
Rs.66.69 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
4 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
--- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|